RSS

DD Support Board and Research Team

Last Post: 12/04/23
Followers: 14
Posts Today: 0
Views Today: 1134

Top 10 Most Recent News Articles

SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 37

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 360

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 258

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 59

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 117

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 138

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 13

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 25

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading

Top 5 Most Recently Viewed Articles

TuHURA Biosciences to Showcase Innovations at Major Investment Event

Updated Category News Views 109

TuHURA Biosciences to Present at Investment Conference TuHURA Biosciences, Inc. (NASDAQ: HURA), a pioneering Phase 3 immune-oncology company at the forefront of developing innovative therapeutics, has announced a significant presentation in the investment world. Management is set to showcase their work at the 27th Annual H.C. Wainwright Global Investment Conference, an...

Continue Reading
PennantPark Investment Corporation Enhances CLO Management Strategy

Updated Category News Views 123

PennantPark Investment Corporation Expands CLO Platform MIAMI — PennantPark Investment Corporation (the “Company”) (NYSE: PNNT) has successfully established a strong foothold in the middle market with the recent closing of a $400.5 million debt securitization through its joint venture, PennantPark Senior Loan Fund, LLC ("PSLF"). This significant achievement is part...

Continue Reading
Freeport-McMoRan Exceeds Earnings Expectations Amid Rising Copper Prices

Updated Category News Views 50

Freeport-McMoRan Exceeds Earnings Estimates In a recent financial report, Freeport-McMoRan (NYSE: FCX) showcased its ability to navigate the dynamic mining landscape, particularly benefitting from the surge in copper prices. The company announced a substantial profit that surpassed third-quarter expectations, drawing significant attention from investors and analysts...

Continue Reading
WellsCare and Celltrion Canada Unite for Pain Relief Solutions

Updated Category News Views 126

WellsCare Expands Reach with Celltrion Partnership WellsCare, a pioneering medical technology startup based in South Korea, has forged a promising alliance with Celltrion Canada, a renowned subsidiary of global biopharmaceutical giant Celltrion. This collaboration marks a significant milestone in the development of advanced wearable technology aimed at offering effective...

Continue Reading
Elon Musk Addresses Violence Concerns Amid Political Tensions

Updated Category News Views 524

Elon Musk Issues Stark Warning on Violence at Rally Elon Musk stirred significant debate after his virtual appearance at a far-right rally in the UK, where he alerted attendees to an impending threat of violence. His stark statement, "violence is coming, fight back, or die," has reverberated through political discussions and media outlets alike. Details of the Rally...

Continue Reading